Evidence map›Paper›PMID 33856455›Full record

ArticleThe Journal of infectious diseases2021

Decreased Use of Broad-Spectrum Antibiotics During the Coronavirus Disease 2019 Epidemic in South Korea.

Sukhyun Ryu, Youngsik Hwang, Sheikh Taslim Ali, Dong-Sook Kim, Eili Y Klein, Eric H Y Lau, Benjamin J Cowling

Open access · hybridAbstract read
In one paragraph

Article in The Journal of infectious diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 33 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Impact of the COVID-19 Pandemic on Hospital Antimicrobial Purchasing in Canada (2018-2021): An Exploratory Analysis.Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Use of antibiotics in Paediatric Primary Health Care before and during the COVID-19 pandemic.Enfermedades infecciosas y microbiologia clinica (English ed.) · 2023
    Observational
  10. Article
  11. Observational
  12. Article
  13. Article
  14. Community antibiotic prescriptions during COVID-19 era: a population-based cohort study among adults.Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases · 2022
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 3 countries.

Sukhyun RyuDepartment of Preventive Medicine, Konyang University College of Medicine, Daejeon, Republic of Korea.ORCID 0000-0002-8915-8167
Youngsik HwangDepartment of Preventive Medicine, Konyang University College of Medicine, Daejeon, Republic of Korea.
Sheikh Taslim AliWorld Health Organization Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong Special Administrative Region, China.
Dong-Sook KimPharmaceutical and Medical Technology Research Team, Department of Research, Health Insurance Review and Assessment Service, Wonju, South Korea.
Eili Y KleinCenter for Disease Dynamics, Economics and Policy, Washington, District of Columbia, USA.
Eric H Y LauWorld Health Organization Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong Special Administrative Region, China.
Benjamin J CowlingWorld Health Organization Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong Special Administrative Region, China.
Hong Kong Science and Technology Parks Corporation · HKKonyang University · KRCenter for Disease Dynamics, Economics & Policy · USHealth Insurance Review and Assessment Service · KR

Funding

National Research Foundation of Korea NRF-2020R1A3066471NCEZID CDC HHS U01 CK000536NCEZID CDC HHS U01 CK000589
6 · The paper itself

Abstract

backgroundEarly in the coronavirus disease 2019 (COVID-19) pandemic, there was a concern over possible increase in antibiotic use due to coinfections among COVID-19 patients in the community. Here, we evaluate the changes in nationwide use of broad-spectrum antibiotics during the COVID-19 epidemic in South Korea.

methodsWe obtained national reimbursement data on the prescription of antibiotics, including penicillin with β-lactamase inhibitors, cephalosporins, fluoroquinolones, and macrolides. We examined the number of antibiotic prescriptions compared with the previous 3 years in the same period from August to July. To quantify the impact of the COVID-19 epidemic on antibiotic use, we developed a regression model adjusting for changes of viral acute respiratory tract infections (ARTIs), which are an important factor driving antibiotic use.

resultsDuring the COVID-19 epidemic in South Korea, the broad-spectrum antibiotic use dropped by 15%-55% compared to the previous 3 years. Overall reduction in antibiotic use adjusting for ARTIs was estimated to be 14%-30%, with a larger impact in children.

conclusionsOur study found that broad-spectrum antibiotic use was substantially reduced during the COVID-19 epidemic in South Korea. This reduction can be in part due to reduced ARTIs as a result of stringent public health interventions including social distancing measures.

Indexed as

Public HealthAdolescentAdultAgedAged, 80 and overAntimicrobial StewardshipBroadly Neutralizing AntibodiesCephalosporinsChildChild, PreschoolCOVID-19FemaleFluoroquinolonesHospitalizationHumansInfantBroadly Neutralizing AntibodiesCephalosporinsFluoroquinolonesMacrolidesPenicillinsantibioticCOVID-19Koreapublic health measurerespiratory virusstewardship

Identifiers

PMID33856455
PMCPMC8083342
OpenAlexW3156729758

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.